142 related articles for article (PubMed ID: 3399187)
1. Cost of pharmaceutical benefits.
Mackereth MB
N Z Med J; 1988 Jul; 101(849):460-1. PubMed ID: 3399187
[No Abstract] [Full Text] [Related]
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
3. What's the estimated cost of a national outpatient Rx program?
Trapnell GR
Pharm Times; 1980 Jan; 46(1):64-8. PubMed ID: 10245259
[No Abstract] [Full Text] [Related]
4. Managing Medicaid drug expenditures.
Sudovar SG; Rein SD
J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
[No Abstract] [Full Text] [Related]
5. A first look at the new Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
[TBL] [Abstract][Full Text] [Related]
6. Impact of prescription card service and mail-order drug programs on employers' prescription drug costs.
Cave DG
Benefits Q; 1994; 10(4):21-30. PubMed ID: 10138423
[TBL] [Abstract][Full Text] [Related]
7. The Medicare prescription drug plan: assisting our older patients.
Klein MN
ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
[TBL] [Abstract][Full Text] [Related]
8. Do drug copayments work?
David J
CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
[No Abstract] [Full Text] [Related]
9. Drug coverage under NHI policy goals--what will really work?
Lerner I
Hosp Formul; 1978 Aug; 13(8):596-7, 600. PubMed ID: 10308294
[No Abstract] [Full Text] [Related]
10. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
Cher DJ; Maclure M
Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
[No Abstract] [Full Text] [Related]
11. Distribution and cost of drugs in a pharmaceutically decentralized health maintenance organization.
Hardigan WD; Slywka GW; Eng HJ
Contemp Pharm Pract; 1980; 3(1):23-30. PubMed ID: 10245109
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
13. How many antibiotic prescriptions are unsubsidised in New Zealand?
Norris P; Funke S; Becket G; Ecke D; Reiter L; Herbison P
N Z Med J; 2006 May; 119(1233):U1951. PubMed ID: 16680168
[TBL] [Abstract][Full Text] [Related]
14. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
Lamers LM; van Vliet RC
Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
[TBL] [Abstract][Full Text] [Related]
15. Plans continue to raise copayments.
Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
[No Abstract] [Full Text] [Related]
16. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
Alexander W
Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
[No Abstract] [Full Text] [Related]
17. Prescription benefit costs rise less steeply.
Manag Care; 2008 Jun; 17(6):53. PubMed ID: 18624171
[No Abstract] [Full Text] [Related]
18. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
[TBL] [Abstract][Full Text] [Related]
19. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
AVMA Group Health & Life Insurance Trust
J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
[No Abstract] [Full Text] [Related]
20. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
